Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Confluent (CFLT) Research & Development (2020 - 2025)

Confluent (CFLT) has disclosed Research & Development for 6 consecutive years, with $121.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development rose 18.53% year-over-year to $121.8 million, compared with a TTM value of $456.2 million through Sep 2025, up 15.98%, and an annual FY2025 reading of $481.7 million, up 14.36% over the prior year.
  • Research & Development was $121.8 million for Q3 2025 at Confluent, up from $116.8 million in the prior quarter.
  • Across five years, Research & Development topped out at $121.8 million in Q3 2025 and bottomed at $24.3 million in Q1 2021.
  • Average Research & Development over 5 years is $79.7 million, with a median of $85.3 million recorded in 2023.
  • Peak annual rise in Research & Development hit 159.3% in 2021, while the deepest fall reached 6.19% in 2021.
  • Year by year, Research & Development stood at $56.7 million in 2021, then grew by 26.68% to $71.8 million in 2022, then increased by 21.08% to $86.9 million in 2023, then soared by 32.13% to $114.9 million in 2024, then grew by 5.98% to $121.8 million in 2025.
  • Business Quant data shows Research & Development for CFLT at $121.8 million in Q3 2025, $116.8 million in Q1 2025, and $114.9 million in Q4 2024.